免疫疗法
癌症研究
STK11段
彭布罗利珠单抗
肿瘤微环境
癌症
生物
医学
免疫系统
免疫学
内科学
克拉斯
结直肠癌
作者
Leanne G. Ahronian,Soumyadip Sahu,Minjie Zhang,Ayushi S. Patel,Ke Geng,Reshmee Bhattacharya,Gerald S. Falchook,Jonathan W. Goldman,Alexander I. Spira,Salman R. Punekar,David R. Spigel,Judy S. Wang,Ferdinandos Skoulidis,Janaye Stephens,Mary Meynardie,Jaylen M. Powell,Alfonso Lopez,Michela Ranieri,Magdalena A. Ploszaj,Yi Jer Tan
出处
期刊:Cancer Research
[American Association for Cancer Research]
日期:2025-08-29
卷期号:85 (20): 3966-3982
被引量:1
标识
DOI:10.1158/0008-5472.can-25-0998
摘要
Targeting CoREST with TNG260 sensitizes STK11-deficient non-small cell lung cancer to anti-PD-1 immunotherapy, offering a potential treatment for patients not served by existing therapies. See related commentary by Lin and Shen, p. 3821.
科研通智能强力驱动
Strongly Powered by AbleSci AI